Waters Of Batesville, The | |
958 E Hwy 46, Batesville, Indiana 47006 | |
(812) 934-2436 | |
Name | Waters Of Batesville, The |
---|---|
Location | 958 E Hwy 46, Batesville, Indiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 86 |
Occupancy Rate | 53.6% |
Medicare ID (CCN) | 155233 |
Legal Business Name | Major Hospital |
Ownership Type | Non Profit - Corporation |
NPI Number | 1245278829 |
Organization Name | MAJOR HOSPITAL |
Doing Business As | THE WATERS OF BATESVILLE |
Address | 958 Highway 46 E, Batesville, IN 47006 |
Phone Number | 812-934-2436 |
News Archive
Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies.
A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.
Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013.
› Verified 3 days ago
NPI Number | 1316150568 |
Organization Name | HEALTHCARE CENTERS OF INDIANA, LLC |
Doing Business As | THE WATERS OF BATESVILLE |
Address | 958 Highway 46 E, Batesville, IN 47006 |
Phone Number | 812-934-2436 |
News Archive
Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies.
A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.
Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies.
A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.
Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.81 | 14.46 |
Percentage of long-stay residents who lose too much weight | 0.54 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.17 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.2 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.06 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 22.95 | 5.05 |
Percentage of long-stay residents who were physically restrained | 2.06 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.58 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 35.57 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 13.94 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 13.18 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.65 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 11.01 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.11 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.6 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 61.14 | 95.98 |
Percentage of short-stay residents who made improvements in function | 80.35 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 29.89 | 82.93 |
News Archive
Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies.
A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.
Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness.
SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013.
› Verified 3 days ago